Related Experiment Video

Updated: Jul 10, 2026

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow
07:00

In Vitro 3D Cell-Cultured Arterial Models for Studying Vascular Drug Targeting Under Flow

Published on: March 14, 2021

Effect of blood flow on drug release from DES: an experimental study

P R Umashankar, P R Hari, K Sreenivasan

    International Journal of Cardiology
    |November 17, 2007
    PubMed

    More Related Videos

    A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies08:59

    A Freeze-Thawing Method to Prepare Chitosan-Poly(vinyl alcohol) Hydrogels Without Crosslinking Agents and Diflunisal Release Studies

    Published on: January 14, 2020

    In Vitro Model of Physiological and Pathological Blood Flow with Application to Investigations of Vascular Cell Remodeling07:30

    In Vitro Model of Physiological and Pathological Blood Flow with Application to Investigations of Vascular Cell Remodeling

    Published on: November 3, 2015

    Related Concept Videos

    Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

    Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

    Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
    Modified-Release Drug Delivery Systems: Drug Release Characteristics01:22

    Modified-Release Drug Delivery Systems: Drug Release Characteristics

    Drug release from modified-release dosage forms is designed to achieve specific therapeutic effects by controlling the rate and extent of drug release. The classification of these drug release systems is based on key pharmacokinetic assumptions: drug disposition follows first-order kinetics, drug release is the rate-limiting step in absorption, and the released drug is rapidly and completely absorbed.There are four major models of drug release patterns. The first model is the slow zero-order...
    Modified-Release Drug Delivery Systems: Influencing Factors01:20

    Modified-Release Drug Delivery Systems: Influencing Factors

    Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
    Factors Affecting Drug Distribution: Organ Perfusion Rate01:15

    Factors Affecting Drug Distribution: Organ Perfusion Rate

    Drug distribution within the body is a complex process influenced by several factors, including perfusion rate, the rate at which the bloodstream transports drugs to tissue. This limitation becomes particularly significant when dealing with highly lipophilic drugs. In such cases, the rate at which the drug can move across membranes is crucial, and if the membrane is highly permeable to the drug, distribution becomes rate-limited by perfusion.
    Perfusion rate-limited distribution relies on the...
    Modified-Release Drug Delivery Systems: Bioavailability01:30

    Modified-Release Drug Delivery Systems: Bioavailability

    Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
    Blood Flow01:29

    Blood Flow

    Blood is pumped by the heart into the aorta, the largest artery in the body, and then into increasingly smaller arteries, arterioles, and capillaries. The velocity of blood flow decreases with increased cross-sectional blood vessel area. As blood returns to the heart through venules and veins, its velocity increases. The movement of blood is encouraged by smooth muscle in the vessel walls, the movement of skeletal muscle surrounding the vessels, and one-way valves that prevent backflow.